I did think Dr. Gottlieb was slightly too booster-ish -- of big pharma's agenda, but he clearly was one of the only pre-eminent members of his respective industry / career calling. . . ever to serve in the RMS Trump-tanic [Mal-] administration.
And I say that across all cabinet level positions. That he stayed as long as he did. . . may be a bigger mystery, than that he is now hopping a life-boat, off the ice-berg stricken behemoth. Here's a bit, from John, at Endpoints News:
. . . .Gottlieb arrived at the FDA shortly after the Trump administration took office, vowing to uphold the gold standard in drug development while doing everything possible to facilitate drug makers’ work — at least for the legitimate players.
He has been enormously popular in his short stint, with the vast majority of biopharma execs acclaiming his work at the agency. He’s also been popular with President Donald Trump, finding a secure spot for himself in an administration noted for rapid turnover.
So what happened here?
Just weeks ago Gottlieb insisted on Twitter that rumors of his pending departure from the agency were flat wrong. . . .
I think, in time, we will hear exactly why he left -- and it may be as simple as he realized he should jump back into the private sector before 45 is actually impeached. Onward. Shrove Tuesday fare tonight, it is. . . . smile.
नमस्ते
No comments:
Post a Comment